Saponarin: a shield against coronary heart disease-related myocardial injury via NF-κB pathway inhibition
- 1Department of Cardiovascular Surgery, Tianjin Chest Hospital
Abstract
Objective: Coronary heart disease (CHD) is a major cardiovascular disorder characterized by myocardial ischemia and injury. Saponarin is a natural flavonoid glycoside with anti-inflammatory and tissue-protective activities. This study evaluated the protective effect of saponarin against CHD-related myocardial injury and explored the potential involvement of the NF-κB signaling pathway.
Methods: H9C2 cells were exposed to DOX alone or co-treated with saponarin. Cell viability was assessed using CCK-8, and LDH release was used to assess cell injury. Cell apoptosis was assessed by flow cytometry and cleaved caspase-3 expression using western blotting. Inflammatory responses were evaluated by measuring IL-1 β and IL-6 mRNA expression using RT-qPCR. NF-κB pathway activity was assessed by western blotting and immunofluorescence staining, and rescue experiments were performed using the NF-κB pathway activator RANKL. In addition, a CHD rat model induced by high-fat emulsion combined with pituitrin administration was used to evaluate the in vivo cardioprotective effect of saponarin. Cardiac function was assessed by echocardiography, myocardial infarct area was evaluated by TTC staining, myocardial histopathological injury was examined by HE staining, myocardial apoptosis was detected by TUNEL staining.
Results: Saponarin improved DOX-induced H9C2 cell injury, as reflected by increased cell viability and reduced LDH release. Saponarin also reduced apoptosis, cleaved caspase-3 expression, and IL-1 β and IL-6 mRNA expression in DOX-treated H9C2 cells. In CHD rats, saponarin improved cardiac function, reduced myocardial infarct area, alleviated myocardial histopathological injury, and decreased serum CK, CK-MB, LDH, and cTnT levels. In addition, saponarin reduced myocardial apoptosis and inflammatory factor expression in CHD rats. Given the reported regulatory effect of saponarin on NF-κB p65 and the role of NF-κB p65 in myocardial injury, NF-κB signaling was further investigated. Mechanistically, saponarin decreased p-I κ B α /I κ B α and p-NF-κB/NF-κB ratios and reduced NF-κB p65 nuclear translocation. RANKL-mediated NF-κB pathway activation partially attenuated the protective effects of saponarin against DOX-induced H9C2 cell injury.
Conclusion: Saponarin alleviated CHD-related myocardial injury, ameliorated cardiac dysfunction, and attenuated apoptosis and inflammatory responses. These protective effects may involve suppression of NF-κB signaling.
Related
- SGLT2i protects against myocardial I/R-induced coronary microvascular injury by inhibiting glycocalyx degradation
- Right Coronary Artery Thrombosis Causing ST-Elevation Myocardial Infarction After a Coronary Artery Disease Reporting and Data System Score of 0, With Disseminated Intravascular Coagulation During Idiopathic Acute Pancreatitis: A Case Report
- Inhibition of PCSK9 protects against myocardial ischemia-reperfusion injury by suppressing ferroptosis via negative regulation of the P65/MMP9 pathway
- Variational autoencoders can detect coronary artery disease in myocardial perfusion SPECT images
- Sex differences in the diabetes-related risk of incident myocardial infarction and relationship to established coronary heart disease risk factors: the Tromsø Study (1979–2016)
BibTeX
@article{yan2026saponarin,
title = {{Saponarin: a shield against coronary heart disease-related myocardial injury via NF-κB pathway inhibition}},
author = {Linan Yan and Yin Yang and Junshan Li and Dongyan Yang and Dong Wei and Lianqun Wang},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = nov,
doi = {10.3389/fcvm.2026.1932689},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1932689/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Saponarin: a shield against coronary heart disease-related myocardial injury via NF-κB pathway inhibition
AU - Linan Yan
AU - Yin Yang
AU - Junshan Li
AU - Dongyan Yang
AU - Dong Wei
AU - Lianqun Wang
PY - 2026
DA - 2026/11/02
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1932689
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1932689/full
AB - Objective: Coronary heart disease (CHD) is a major cardiovascular disorder characterized by myocardial ischemia and injury. Saponarin is a natural flavonoid glycoside with anti-inflammatory and tissue-protective activities. This study evaluated the protective effect of saponarin against CHD-related myocardial injury and explored the potential involvement of the NF-κB signaling pathway. Methods: H9C2 cells were exposed to DOX alone or co-treated with saponarin. Cell viability was assessed using CCK-8, and LDH release was used to assess cell injury. Cell apoptosis was assessed by flow cytometry and cleaved caspase-3 expression using western blotting. Inflammatory responses were evaluated by measuring IL-1 β and IL-6 mRNA expression using RT-qPCR. NF-κB pathway activity was assessed by western blotting and immunofluorescence staining, and rescue experiments were performed using the NF-κB pathway activator RANKL. In addition, a CHD rat model induced by high-fat emulsion combined with pituitrin administration was used to evaluate the in vivo cardioprotective effect of saponarin. Cardiac function was assessed by echocardiography, myocardial infarct area was evaluated by TTC staining, myocardial histopathological injury was examined by HE staining, myocardial apoptosis was detected by TUNEL staining. Results: Saponarin improved DOX-induced H9C2 cell injury, as reflected by increased cell viability and reduced LDH release. Saponarin also reduced apoptosis, cleaved caspase-3 expression, and IL-1 β and IL-6 mRNA expression in DOX-treated H9C2 cells. In CHD rats, saponarin improved cardiac function, reduced myocardial infarct area, alleviated myocardial histopathological injury, and decreased serum CK, CK-MB, LDH, and cTnT levels. In addition, saponarin reduced myocardial apoptosis and inflammatory factor expression in CHD rats. Given the reported regulatory effect of saponarin on NF-κB p65 and the role of NF-κB p65 in myocardial injury, NF-κB signaling was further investigated. Mechanistically, saponarin decreased p-I κ B α /I κ B α and p-NF-κB/NF-κB ratios and reduced NF-κB p65 nuclear translocation. RANKL-mediated NF-κB pathway activation partially attenuated the protective effects of saponarin against DOX-induced H9C2 cell injury. Conclusion: Saponarin alleviated CHD-related myocardial injury, ameliorated cardiac dysfunction, and attenuated apoptosis and inflammatory responses. These protective effects may involve suppression of NF-κB signaling.
SN - 2297-055X
ER -